🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The incidence of brain metastasis of Her2-negative breast cancer is high, w...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-06-15
Trial ID
NCT06462079
Treatments Being Tested
The main purpose of this study is to see whether addition of TPI 287 to FSR...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2014-10-09
Trial ID
NCT02187822
Treatments Being Tested
This phase II clinical trial studies how well craniospinal irradiation (CSI...
Status
Recruiting
Location
University of California San Francisco
Start Date
2025-03-03
Trial ID
NCT06518057
This is a single arm study of abemaciclib and endocrine therapy with stereo...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2021-11-30
Trial ID
NCT04923542
Treatments Being Tested
The purpose of this study is to determine the efficacy of BRain-AVOidant pr...
Status
Not Yet Recruiting
Location
University of Miami
Start Date
2026-10-01
Trial ID
NCT07789912
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as irinotecan and temozolomide,...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2005-02
Trial ID
NCT00617539
Treatments Being Tested
The aim of the study is to generate patient-derived organoids (PDOs) from b...
Status
Recruiting
Location
Guy's and St. Thomas NHS Foundation Trust
Start Date
2025-05-27
Trial ID
NCT06468124
A phase I clinical trial (a type of research study) for people with human e...
Status
Not Yet Recruiting
Location
Miami Cancer Institute at Baptist Health, Inc.
Start Date
2026-06
Trial ID
NCT07454668
Treatments Being Tested
Determine how safe and effective lapatinib is when used to treat patients w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2005-12-02
Trial ID
NCT00263588
Treatments Being Tested
Sorafenib is a new type of anti-cancer drug. It belongs to a new class of m...
Status
Completed
Location
Memoral Sloan Kettering Cancer Center
Start Date
2012-11-05
Trial ID
NCT01724606
Treatments Being Tested